Understanding how metabolism affects pancreatic cell changes and cancer development
Metabolic regulation of pancreatic metaplasia and neoplasia
['FUNDING_CAREER'] · UNIVERSITY OF MICHIGAN AT ANN ARBOR · NIH-10985624
This study is looking at how changes in the way cells use energy might help certain pancreatic cells change into a different type of cell, which could be important for understanding early signs of pancreatic cancer, and it aims to find ways to prevent it.
Quick facts
| Phase | ['FUNDING_CAREER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF MICHIGAN AT ANN ARBOR (nih funded) |
| Locations | 1 site (ANN ARBOR, UNITED STATES) |
| Trial ID | NIH-10985624 on ClinicalTrials.gov |
What this research studies
This research investigates how changes in cell metabolism influence the transformation of pancreatic acinar cells into duct-like cells, a process known as acinar-to-ductal metaplasia (ADM). The study aims to understand the metabolic alterations that occur during this process and how they may contribute to the development of pancreatic cancer. By using genetically engineered mouse models and advanced metabolic analysis techniques, the researchers will explore the role of specific enzymes and metabolic pathways in regulating these cellular changes. Patients may benefit from insights gained about the early stages of pancreatic cancer and potential preventive strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk for pancreatic cancer, particularly those with a history of pancreatic injury or genetic predispositions.
Not a fit: Patients with established pancreatic cancer or those without any risk factors for pancreatic disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for preventing pancreatic cancer by targeting metabolic processes involved in early cell changes.
How similar studies have performed: Previous research has shown promising results in understanding metabolic changes in cancer, suggesting that this approach may yield valuable insights.
Where this research is happening
ANN ARBOR, UNITED STATES
- UNIVERSITY OF MICHIGAN AT ANN ARBOR — ANN ARBOR, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: RADYK, MEGAN DEANNA — UNIVERSITY OF MICHIGAN AT ANN ARBOR
- Study coordinator: RADYK, MEGAN DEANNA
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Cancer Cause, Cancer Etiology, Cancer Genes